Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 26 |
| Active Pipeline (Recruiting Now) | 4 (1) |
| Completed vs Stopped Early | 5 / 0 (0.0%) |
| Median Closed Actual Enrollment | 110 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Interactive Dossier, benchmark peers in Infectious Disease and Vaccines, or review the Healthcare Price & Patent Cliff Crosswalk.